<p>Fortrea Holdings Inc.（FTRE）已召开第一季度财报电话会议。请继续阅读会议的主要亮点。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
<p>Fortrea Holdings 最近的财报电话会议传达了谨慎乐观的语气，管理层强调尽管面临短期收入和现金流压力，但运营进展强劲，盈利能力正在改善。高管们指出，预订量上升、利润率扩张和成本节约是公司转型取得进展的证据，尽管他们承认价格、通过收入和客户集中度带来的逆风。</p>
<h2>商业执行力改善和订单与发票比率上升</h2>
<p>Fortrea 强调商业执行力的改善，第一季度的订单与发票比率为 1.15 倍，过去 12 个月的比率为 1.05 倍，标志着连续第三个季度达到或超过 1.1 倍。管理层指出新的生物技术胜利和更健康的项目管道是销售引擎获得动力的迹象，这些奖项将转化为收入，从而支持增长。</p>
<h2>收入规模和积压支持多年的增长</h2>
<p>第一季度收入为 6.365 亿美元，得益于 78 亿美元的可观积压，提供了多年的可见性。尽管与去年相比，收入略有下降，但公司重申了 2026 年收入展望为 25.5 亿至 26.5 亿美元，认为当前的积压和近期的预订支撑了对长期增长轨迹的信心。</p>
<h2>调整后 EBITDA 扩张信号盈利能力的转变</h2>
<p>盈利能力显著改善，调整后 EBITDA 从去年的 3030 万美元上升至 4700 万美元，增长约 55%。调整后的净收入攀升至 1520 万美元，调整后的每股收益达到 0.16 美元，管理层主要将其归因于成本措施和更好的项目组合，因为 Fortrea 正在向更高利润率的工作转型。</p>
<h2>现金流和资产负债表朝着正确的方向发展</h2>
<p>现金指标虽然仍为负值，但显示出显著进展，运营现金流改善至负 1700 万美元，较之前的负 1.242 亿美元有所改善，自由现金流改善至负 2500 万美元，较之前的负 1.271 亿美元有所改善。公司报告可用流动性超过 5 亿美元，债务回购后利息支出降低，表明财务基础更加稳固。</p>
<h2>适度调整推动早期成本节约和利润提升</h2>
<p>Fortrea 的适度调整计划提前交付，第一季度实现了近 1600 万美元的总成本节约和超过 900 万美元的净节约。这些结果与全年的目标（7000 万至 8000 万美元的总成本节约和 4000 万至 5000 万美元的净节约）相比，支持公司在未来几年稳步扩大利润率的努力。</p>
<h2>FIT 平台的推出旨在实现技术主导的差异化</h2>
<p>Fortrea Intelligent Technology 的推出是其 Xcellerate 套件中嵌入的 AI 驱动平台，是一个关键的战略亮点。早期客户反馈积极，管理层相信 FIT 可以提高胜率和运营效率，可能在竞争激烈的合同研究市场中创造技术优势。</p>
<h2>中国和临床药理学显示健康增长</h2>
<p>管理层报告称，中国管道机会实现了两位数的增长，并取得了显著胜利，突显该地区在投资组合中的日益重要性。利兹临床研究单位完成了免疫性血小板减少症项目的首次人体给药，临床药理学授权实现了自该单位成立以来的最佳第一季度业绩。</p>
<h2>运营执行和质量资质改善</h2>
<p>在运营方面，Fortrea 提到更快的现场激活和启动时间，以及其全球现场导航程序扩展到中国和日本等市场。公司继续看到净推荐值的稳定增长，其质量资质得到了加强，首席质量官当选为一个主要行业协会的主席。</p>
<h2>清晰的中期 EBITDA 利润率路径</h2>
<p>高管们重申了在未来三到五年内实现中期调整后 EBITDA 利润率的路径，推动因素包括收入多样化、增长和持续的效率举措。管理层将第一季度的利润率扩张和成本节约视为长期盈利计划按轨道推进的早期证明，尽管短期内存在噪音。</p>
<h2>收入下降突显短期压力</h2>
<p>本季度的主要瑕疵是收入同比下降 2.3%，降至 6.365 亿美元，其中包括 3.2% 的恒定货币下降，部分被货币收益抵消。收入短缺主要与较低的通过成本和功能服务提供商（FSP）产品的持续压力有关，显示出收入恢复仍在进行中。</p>
<h2>FSP 定价让步对积压消耗产生影响</h2>
<p>第一季度的积压消耗率为 8.2%，低于前一季度，部分反映了之前披露的大型制药 FSP 合同的定价让步。管理层指出，重置的费率卡现在已完全融入结果中，虽然压低了收入，但保持了关系，并应在未来提供更可预测的交易量。</p>
<h2>客户集中度仍然是关键风险因素</h2>
<p>电话会议强调了持续的客户集中风险，前 10 名客户贡献了第一季度收入的 54.8%，而最大单一客户占 17.2%。尽管 Fortrea 正在努力多样化其客户基础，但投资者可能会密切关注对少数大型客户的依赖如何影响定价、合同续签和收入波动。</p>
<h2>尽管改善，短期现金流仍为负值</h2>
<p>尽管同比大幅改善，Fortrea 的经营现金流在本季度仍为负，达到 1700 万美元，自由现金流为负 2500 万美元。管理层维持了到 2026 年晚些时候实现经营现金流为正的目标，这表明投资者应预期现金流的改善将是渐进的，而非突发的。</p>
<h2>通过收入和可变薪酬造成利润压力</h2>
<p>预计通过成本将保持在 2025 年水平以下，这有利于利润率，但在 2026 年将对报告收入施加压力。同时，可变薪酬正在正常化，预计全年将增加约 6000 万美元的费用，尽管基础经营收益有所改善，但这将对短期盈利能力造成显著拖累。</p>
<h2>人工智能的影响和时机仍不确定</h2>
<p>尽管客户对 FIT 平台表示欢迎，管理层警告称与人工智能相关的试点和整合仍处于初期阶段。潜在的生产力收益和对定价的任何影响可能会随着时间的推移而显现，使得人工智能在短期内对收益的贡献更像是一个战略选择，而非近期的驱动因素。</p>
<h2>指引和前景强化渐进改善的故事</h2>
<p>Fortrea 重申了 2026 年的收入指引为 25.5 亿至 26.5 亿美元，调整后的 EBITDA 为 1.9 亿至 2.2 亿美元，同时目标是在三到五年内实现中等十几的 EBITDA 利润率。公司预计第二季度将实现适度的环比收入增长和轻微的调整后 EBITDA 增加，这得益于 78 亿美元的订单积压、改善的订单、持续的成本节约以及在 2026 年实现经营现金流为正的目标。</p>
<p>Fortrea 的财报电话会议描绘了一幅公司稳步修复基本面的图景，结合了更强的订单、成本控制和利润率提升，但仍面临挑战的收入和负现金流。对于投资者而言，故事的关键在于管理层能否将稳固的订单积压、新的技术举措和早期的节省转化为未来几年的持续增长和现金生成，同时管理定价压力和客户集中风险。</p>

FTRE

医疗业 ETF - SPDR

生物科技 ETF - VanEck Vectors

<p>Fortrea Holdings Inc. 发布了第一季度财报，强调盈利能力改善，调整后的 EBITDA 上升至 4700 万美元，尽管收入下降 2.3% 至 6.365 亿美元。公司强调了强劲的运营进展，账单比率为 1.15 倍，以及 78 亿美元的订单积压支持长期增长。节省成本措施带来了近 1600 万美元的节省，推出的 AI 驱动平台旨在提高运营效率。然而，客户集中度仍然是一个风险，主要客户对收入的贡献显著</p>

<p>Fortrea Holdings Inc. ((FTRE)) has held its Q1 earnings call. Read on for the main highlights of the call.</p>
<div class="lb-trans"><p>Fortrea Holdings Inc.（FTRE）已召开第一季度财报电话会议。请继续阅读会议的主要亮点。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
</div><p>Fortrea Holdings’ latest earnings call struck a cautiously optimistic tone, as management emphasized strong operational progress and improving profitability despite near-term revenue and cash flow pressures. Executives highlighted rising bookings, margin expansion and cost savings as evidence that the turnaround is gaining traction, even as they acknowledged headwinds from pricing, pass-through revenue and customer concentration.</p>
<div class="lb-trans"><p>Fortrea Holdings 最近的财报电话会议传达了谨慎乐观的语气，管理层强调尽管面临短期收入和现金流压力，但运营进展强劲，盈利能力正在改善。高管们指出，预订量上升、利润率扩张和成本节约是公司转型取得进展的证据，尽管他们承认价格、通过收入和客户集中度带来的逆风。</p>
</div><h2>Improved Commercial Traction and Book-to-Bill Momentum</h2>
<div class="lb-trans"><h2>商业执行力改善和订单与发票比率上升</h2>
</div><p>Fortrea underscored improving commercial execution, with a Q1 book-to-bill ratio of 1.15x and a trailing 12-month figure of 1.05x, marking a third straight quarter at or above 1.1x. Management pointed to new biotech wins and a healthier pipeline as signs that the sales engine is gaining momentum and should support growth as these awards convert into revenue.</p>
<div class="lb-trans"><p>Fortrea 强调商业执行力的改善，第一季度的订单与发票比率为 1.15 倍，过去 12 个月的比率为 1.05 倍，标志着连续第三个季度达到或超过 1.1 倍。管理层指出新的生物技术胜利和更健康的项目管道是销售引擎获得动力的迹象，这些奖项将转化为收入，从而支持增长。</p>
</div><h2>Revenue Scale and Backlog Support Multi-Year Growth</h2>
<div class="lb-trans"><h2>收入规模和积压支持多年的增长</h2>
</div><p>First-quarter revenue came in at $636.5 million, backed by a sizable $7.8 billion backlog that provides multi-year visibility. Despite a modest top-line decline versus last year, the company reaffirmed its 2026 revenue outlook of $2.55 billion to $2.65 billion, arguing that the current backlog and recent bookings underpin confidence in the long-term growth trajectory.</p>
<div class="lb-trans"><p>第一季度收入为 6.365 亿美元，得益于 78 亿美元的可观积压，提供了多年的可见性。尽管与去年相比，收入略有下降，但公司重申了 2026 年收入展望为 25.5 亿至 26.5 亿美元，认为当前的积压和近期的预订支撑了对长期增长轨迹的信心。</p>
</div><h2>Adjusted EBITDA Expansion Signals Profitability Turnaround</h2>
<div class="lb-trans"><h2>调整后 EBITDA 扩张信号盈利能力的转变</h2>
</div><p>Profitability improved sharply, with adjusted EBITDA rising to $47 million from $30.3 million a year ago, a roughly 55% jump. Adjusted net income climbed to $15.2 million and adjusted EPS reached $0.16, which management attributed mainly to cost actions and a better project mix as Fortrea shifts toward higher-margin work.</p>
<div class="lb-trans"><p>盈利能力显著改善，调整后 EBITDA 从去年的 3030 万美元上升至 4700 万美元，增长约 55%。调整后的净收入攀升至 1520 万美元，调整后的每股收益达到 0.16 美元，管理层主要将其归因于成本措施和更好的项目组合，因为 Fortrea 正在向更高利润率的工作转型。</p>
</div><h2>Cash Flow and Balance Sheet Move in the Right Direction</h2>
<div class="lb-trans"><h2>现金流和资产负债表朝着正确的方向发展</h2>
</div><p>Cash metrics, while still negative, showed substantial progress as operating cash flow improved to negative $17 million from negative $124.2 million and free cash flow to negative $25 million from negative $127.1 million. The company reported more than $0.5 billion in available liquidity and lower interest expense after debt repurchases, signaling a firmer financial footing.</p>
<div class="lb-trans"><p>现金指标虽然仍为负值，但显示出显著进展，运营现金流改善至负 1700 万美元，较之前的负 1.242 亿美元有所改善，自由现金流改善至负 2500 万美元，较之前的负 1.271 亿美元有所改善。公司报告可用流动性超过 5 亿美元，债务回购后利息支出降低，表明财务基础更加稳固。</p>
</div><h2>Rightsizing Drives Early Cost Savings and Margin Lift</h2>
<div class="lb-trans"><h2>适度调整推动早期成本节约和利润提升</h2>
</div><p>Fortrea’s rightsizing program is delivering ahead of schedule, with nearly $16 million of gross cost savings and more than $9 million of net savings in Q1 alone. These results compare with full-year targets of $70 million to $80 million gross and $40 million to $50 million net, supporting the company’s effort to steadily expand margins over the coming years.</p>
<div class="lb-trans"><p>Fortrea 的适度调整计划提前交付，第一季度实现了近 1600 万美元的总成本节约和超过 900 万美元的净节约。这些结果与全年的目标（7000 万至 8000 万美元的总成本节约和 4000 万至 5000 万美元的净节约）相比，支持公司在未来几年稳步扩大利润率的努力。</p>
</div><h2>FIT Platform Launch Targets Technology-Led Differentiation</h2>
<div class="lb-trans"><h2>FIT 平台的推出旨在实现技术主导的差异化</h2>
</div><p>The launch of Fortrea Intelligent Technology, an AI-enabled platform embedded in its Xcellerate suite, was a key strategic highlight. Early customer feedback has been positive, and management believes FIT can boost win rates and operational efficiency, potentially creating a technology edge in a competitive contract research market.</p>
<div class="lb-trans"><p>Fortrea Intelligent Technology 的推出是其 Xcellerate 套件中嵌入的 AI 驱动平台，是一个关键的战略亮点。早期客户反馈积极，管理层相信 FIT 可以提高胜率和运营效率，可能在竞争激烈的合同研究市场中创造技术优势。</p>
</div><h2>China and Clinical Pharmacology Show Healthy Growth</h2>
<div class="lb-trans"><h2>中国和临床药理学显示健康增长</h2>
</div><p>Management reported double-digit growth in China pipeline opportunities along with notable wins, underscoring the region’s growing importance in the portfolio. The Leeds clinical research unit completed first-in-human dosing for an immune thrombocytopenia program, and clinical pharmacology authorizations delivered their strongest first quarter since the unit’s founding.</p>
<div class="lb-trans"><p>管理层报告称，中国管道机会实现了两位数的增长，并取得了显著胜利，突显该地区在投资组合中的日益重要性。利兹临床研究单位完成了免疫性血小板减少症项目的首次人体给药，临床药理学授权实现了自该单位成立以来的最佳第一季度业绩。</p>
</div><h2>Operational Execution and Quality Credentials Improve</h2>
<div class="lb-trans"><h2>运营执行和质量资质改善</h2>
</div><p>Operationally, Fortrea cited faster site activation and start-up timelines alongside the expansion of its global site navigator program into markets such as China and Japan. The company continues to see steady gains in Net Promoter Scores, and its quality credentials were reinforced with its Chief Quality Officer elected chair of a major industry association.</p>
<div class="lb-trans"><p>在运营方面，Fortrea 提到更快的现场激活和启动时间，以及其全球现场导航程序扩展到中国和日本等市场。公司继续看到净推荐值的稳定增长，其质量资质得到了加强，首席质量官当选为一个主要行业协会的主席。</p>
</div><h2>Clear Path to Mid-Teens EBITDA Margins</h2>
<div class="lb-trans"><h2>清晰的中期 EBITDA 利润率路径</h2>
</div><p>Executives reiterated a pathway to mid-teens adjusted EBITDA margins over the next three to five years, driven by revenue diversification, growth and ongoing efficiency initiatives. Management framed Q1’s margin expansion and cost savings as early proof points that the long-term profitability plan is on track despite short-term noise.</p>
<div class="lb-trans"><p>高管们重申了在未来三到五年内实现中期调整后 EBITDA 利润率的路径，推动因素包括收入多样化、增长和持续的效率举措。管理层将第一季度的利润率扩张和成本节约视为长期盈利计划按轨道推进的早期证明，尽管短期内存在噪音。</p>
</div><h2>Revenue Decline Highlights Near-Term Pressure</h2>
<div class="lb-trans"><h2>收入下降突显短期压力</h2>
</div><p>The quarter’s main blemish was a 2.3% year-on-year revenue decline to $636.5 million, including a 3.2% constant-currency drop partly offset by currency benefits. The shortfall was primarily tied to lower pass-through costs and lingering pressure in functional service provider, or FSP, offerings, showing that top-line recovery remains a work in progress.</p>
<div class="lb-trans"><p>本季度的主要瑕疵是收入同比下降 2.3%，降至 6.365 亿美元，其中包括 3.2% 的恒定货币下降，部分被货币收益抵消。收入短缺主要与较低的通过成本和功能服务提供商（FSP）产品的持续压力有关，显示出收入恢复仍在进行中。</p>
</div><h2>FSP Pricing Concessions Weigh on Backlog Burn</h2>
<div class="lb-trans"><h2>FSP 定价让步对积压消耗产生影响</h2>
</div><p>Backlog burn of 8.2% in Q1 was lower than the prior quarter, partly reflecting previously disclosed pricing concessions on a large pharma FSP contract. Management noted that the reset rate card is now fully embedded in results, which depresses revenue but preserves the relationship and should provide more predictable volumes going forward.</p>
<div class="lb-trans"><p>第一季度的积压消耗率为 8.2%，低于前一季度，部分反映了之前披露的大型制药 FSP 合同的定价让步。管理层指出，重置的费率卡现在已完全融入结果中，虽然压低了收入，但保持了关系，并应在未来提供更可预测的交易量。</p>
</div><h2>Customer Concentration Remains a Key Risk Factor</h2>
<div class="lb-trans"><h2>客户集中度仍然是关键风险因素</h2>
</div><p>The call highlighted ongoing customer concentration risk, with the top 10 clients contributing 54.8% of Q1 revenue and the largest single customer accounting for 17.2%. While Fortrea is working to diversify its base, investors will likely keep a close eye on how reliance on a handful of large accounts influences pricing, contract renewals and revenue volatility.</p>
<div class="lb-trans"><p>电话会议强调了持续的客户集中风险，前 10 名客户贡献了第一季度收入的 54.8%，而最大单一客户占 17.2%。尽管 Fortrea 正在努力多样化其客户基础，但投资者可能会密切关注对少数大型客户的依赖如何影响定价、合同续签和收入波动。</p>
</div><h2>Short-Term Cash Flow Still Negative Despite Improvement</h2>
<div class="lb-trans"><h2>尽管改善，短期现金流仍为负值</h2>
</div><p>Despite major year-on-year improvement, Fortrea’s operating cash flow remained negative at $17 million and free cash flow at negative $25 million in the quarter. Management maintained its goal of becoming operating cash flow positive later in 2026, suggesting that investors should expect a gradual, rather than sudden, cash inflection.</p>
<div class="lb-trans"><p>尽管同比大幅改善，Fortrea 的经营现金流在本季度仍为负，达到 1700 万美元，自由现金流为负 2500 万美元。管理层维持了到 2026 年晚些时候实现经营现金流为正的目标，这表明投资者应预期现金流的改善将是渐进的，而非突发的。</p>
</div><h2>Pass-Through Revenue and Variable Pay Create Margin Headwinds</h2>
<div class="lb-trans"><h2>通过收入和可变薪酬造成利润压力</h2>
</div><p>Pass-through costs are expected to stay below 2025 levels, which supports margins but puts pressure on reported revenue throughout 2026. At the same time, variable compensation is normalizing, with about $60 million of incremental expense anticipated for the full year, representing a meaningful drag on near-term profitability despite underlying operating gains.</p>
<div class="lb-trans"><p>预计通过成本将保持在 2025 年水平以下，这有利于利润率，但在 2026 年将对报告收入施加压力。同时，可变薪酬正在正常化，预计全年将增加约 6000 万美元的费用，尽管基础经营收益有所改善，但这将对短期盈利能力造成显著拖累。</p>
</div><h2>AI Impact and Timing Still Uncertain</h2>
<div class="lb-trans"><h2>人工智能的影响和时机仍不确定</h2>
</div><p>While the FIT platform was welcomed by customers, management cautioned that AI-related pilots and integrations are still in the early innings. Potential productivity benefits and any influence on pricing will likely emerge over time, leaving the short-term earnings contribution from AI more of a strategic option than a near-term driver.</p>
<div class="lb-trans"><p>尽管客户对 FIT 平台表示欢迎，管理层警告称与人工智能相关的试点和整合仍处于初期阶段。潜在的生产力收益和对定价的任何影响可能会随着时间的推移而显现，使得人工智能在短期内对收益的贡献更像是一个战略选择，而非近期的驱动因素。</p>
</div><h2>Guidance and Outlook Reinforce Gradual Improvement Story</h2>
<div class="lb-trans"><h2>指引和前景强化渐进改善的故事</h2>
</div><p>Fortrea reaffirmed 2026 guidance for revenue of $2.55 billion to $2.65 billion and adjusted EBITDA of $190 million to $220 million while targeting mid-teens EBITDA margins within three to five years. The company expects a modest sequential revenue increase and a slight adjusted EBITDA step-up in Q2, underpinned by a $7.8 billion backlog, improving bookings, ongoing cost savings and a goal of turning operating cash flow positive during 2026.</p>
<div class="lb-trans"><p>Fortrea 重申了 2026 年的收入指引为 25.5 亿至 26.5 亿美元，调整后的 EBITDA 为 1.9 亿至 2.2 亿美元，同时目标是在三到五年内实现中等十几的 EBITDA 利润率。公司预计第二季度将实现适度的环比收入增长和轻微的调整后 EBITDA 增加，这得益于 78 亿美元的订单积压、改善的订单、持续的成本节约以及在 2026 年实现经营现金流为正的目标。</p>
</div><p>Fortrea’s earnings call painted a picture of a company steadily repairing its fundamentals, combining stronger bookings, cost discipline and margin gains with a still-challenged top line and negative cash flow. For investors, the story hinges on whether management can convert a solid backlog, new technology initiatives and early savings into sustained growth and cash generation over the next several years, while managing pricing pressures and customer concentration risks.</p>
<div class="lb-trans"><p>Fortrea 的财报电话会议描绘了一幅公司稳步修复基本面的图景，结合了更强的订单、成本控制和利润率提升，但仍面临挑战的收入和负现金流。对于投资者而言，故事的关键在于管理层能否将稳固的订单积压、新的技术举措和早期的节省转化为未来几年的持续增长和现金生成，同时管理定价压力和客户集中风险。</p>
</div>

Fortrea 财报电话会议：尽管面临收入压力，利润率有所上升